Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death

Carlo Visco; Maria C Tisi; Andrea Evangelista; Alice Di Rocco; Anna-Katharina Zoellner; Vittorio R Zilioli; Stefan Hohaus; Roberta Sciarra; Alessandro Re; Cristina Tecchio; Annalisa Chiappella; Lucia Morello; Guido Gini; Luca Nassi; Tommasina Perrone; Anna L Molinari; Alberto Fabbri; Maria C Cox; Erica Finolezzi; Simone Ferrero; Benedetta Puccini; Isabel Alvarez De Celis; Annalisa Arcari; Dario Marino; Michele Merli; Francesco Piazza; Massimo Gentile; Matteo Pelosini; Giacomo Loseto; Olivier Hermine; Martin Dreyling; Marco Ruggeri; Maurizio Martelli; Eva Hoster; Umberto Vitolo; Fondazione Italiana Linfomi and the Mantle Cell Lymphoma Network

doi:10.1111/bjh.15643

Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death

Carlo Visco, Maria C Tisi, Andrea Evangelista, Alice Di Rocco, Anna-Katharina Zoellner, Vittorio R Zilioli, Stefan Hohaus, Roberta Sciarra, Alessandro Re, Cristina Tecchio, Annalisa Chiappella, Lucia Morello, Guido Gini, Luca Nassi, Tommasina Perrone, Anna L Molinari, Alberto Fabbri, Maria C Cox, Erica Finolezzi, Simone FerreroBenedetta Puccini, Isabel Alvarez De Celis, Annalisa Arcari, Dario Marino, Michele Merli, Francesco Piazza, Massimo Gentile, Matteo Pelosini, Giacomo Loseto, Olivier Hermine, Martin Dreyling, Marco Ruggeri, Maurizio Martelli, Eva Hoster, Umberto Vitolo, Fondazione Italiana Linfomi and the Mantle Cell Lymphoma Network

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	940-944
Number of pages	5
Journal	British Journal of Haematology
Volume	185
Issue number	5
DOIs	https://doi.org/10.1111/bjh.15643
Publication status	Published - Jun 2019

Keywords

allogeneic transplant
cytarabine
mantle cell lymphoma
prognosis
refractory

Access to Document

10.1111/bjh.15643

https://pubmed.ncbi.nlm.nih.gov/30407625

Cite this

Visco, C., Tisi, M. C., Evangelista, A., Di Rocco, A., Zoellner, A-K., Zilioli, V. R., Hohaus, S., Sciarra, R., Re, A., Tecchio, C., Chiappella, A., Morello, L., Gini, G., Nassi, L., Perrone, T., Molinari, A. L., Fabbri, A., Cox, M. C., Finolezzi, E., ... Network, F. I. L. A. T. M. C. L. (2019). Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death. British Journal of Haematology, 185(5), 940-944. https://doi.org/10.1111/bjh.15643

Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death. / Visco, Carlo; Tisi, Maria C; Evangelista, Andrea; Di Rocco, Alice; Zoellner, Anna-Katharina; Zilioli, Vittorio R; Hohaus, Stefan; Sciarra, Roberta; Re, Alessandro; Tecchio, Cristina; Chiappella, Annalisa; Morello, Lucia; Gini, Guido; Nassi, Luca; Perrone, Tommasina; Molinari, Anna L; Fabbri, Alberto; Cox, Maria C; Finolezzi, Erica; Ferrero, Simone; Puccini, Benedetta; Alvarez De Celis, Isabel; Arcari, Annalisa; Marino, Dario; Merli, Michele; Piazza, Francesco; Gentile, Massimo; Pelosini, Matteo; Loseto, Giacomo; Hermine, Olivier; Dreyling, Martin; Ruggeri, Marco; Martelli, Maurizio; Hoster, Eva; Vitolo, Umberto; Network, Fondazione Italiana Linfomi and the Mantle Cell Lymphoma.

In: British Journal of Haematology, Vol. 185, No. 5, 06.2019, p. 940-944.

Research output: Contribution to journal › Article › peer-review

Visco, C, Tisi, MC, Evangelista, A, Di Rocco, A, Zoellner, A-K, Zilioli, VR, Hohaus, S, Sciarra, R, Re, A, Tecchio, C, Chiappella, A, Morello, L, Gini, G, Nassi, L, Perrone, T, Molinari, AL, Fabbri, A, Cox, MC, Finolezzi, E, Ferrero, S, Puccini, B, Alvarez De Celis, I, Arcari, A, Marino, D, Merli, M, Piazza, F, Gentile, M, Pelosini, M, Loseto, G, Hermine, O, Dreyling, M, Ruggeri, M, Martelli, M, Hoster, E, Vitolo, U & Network, FILATMCL 2019, 'Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death', British Journal of Haematology, vol. 185, no. 5, pp. 940-944. https://doi.org/10.1111/bjh.15643

Visco, Carlo ; Tisi, Maria C ; Evangelista, Andrea ; Di Rocco, Alice ; Zoellner, Anna-Katharina ; Zilioli, Vittorio R ; Hohaus, Stefan ; Sciarra, Roberta ; Re, Alessandro ; Tecchio, Cristina ; Chiappella, Annalisa ; Morello, Lucia ; Gini, Guido ; Nassi, Luca ; Perrone, Tommasina ; Molinari, Anna L ; Fabbri, Alberto ; Cox, Maria C ; Finolezzi, Erica ; Ferrero, Simone ; Puccini, Benedetta ; Alvarez De Celis, Isabel ; Arcari, Annalisa ; Marino, Dario ; Merli, Michele ; Piazza, Francesco ; Gentile, Massimo ; Pelosini, Matteo ; Loseto, Giacomo ; Hermine, Olivier ; Dreyling, Martin ; Ruggeri, Marco ; Martelli, Maurizio ; Hoster, Eva ; Vitolo, Umberto ; Network, Fondazione Italiana Linfomi and the Mantle Cell Lymphoma. / Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death. In: British Journal of Haematology. 2019 ; Vol. 185, No. 5. pp. 940-944.

@article{08544f3bf37b4205b94e3565fa235eee,

title = "Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death",

keywords = "allogeneic transplant, cytarabine, mantle cell lymphoma, prognosis, refractory",

author = "Carlo Visco and Tisi, {Maria C} and Andrea Evangelista and {Di Rocco}, Alice and Anna-Katharina Zoellner and Zilioli, {Vittorio R} and Stefan Hohaus and Roberta Sciarra and Alessandro Re and Cristina Tecchio and Annalisa Chiappella and Lucia Morello and Guido Gini and Luca Nassi and Tommasina Perrone and Molinari, {Anna L} and Alberto Fabbri and Cox, {Maria C} and Erica Finolezzi and Simone Ferrero and Benedetta Puccini and {Alvarez De Celis}, Isabel and Annalisa Arcari and Dario Marino and Michele Merli and Francesco Piazza and Massimo Gentile and Matteo Pelosini and Giacomo Loseto and Olivier Hermine and Martin Dreyling and Marco Ruggeri and Maurizio Martelli and Eva Hoster and Umberto Vitolo and Network, {Fondazione Italiana Linfomi and the Mantle Cell Lymphoma}",

year = "2019",

month = jun,

doi = "10.1111/bjh.15643",

language = "English",

volume = "185",

pages = "940--944",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley & Sons, Ltd (10.1111)",

number = "5",

}

TY - JOUR

T1 - Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death

AU - Visco, Carlo

AU - Tisi, Maria C

AU - Evangelista, Andrea

AU - Di Rocco, Alice

AU - Zoellner, Anna-Katharina

AU - Zilioli, Vittorio R

AU - Hohaus, Stefan

AU - Sciarra, Roberta

AU - Re, Alessandro

AU - Tecchio, Cristina

AU - Chiappella, Annalisa

AU - Morello, Lucia

AU - Gini, Guido

AU - Nassi, Luca

AU - Perrone, Tommasina

AU - Molinari, Anna L

AU - Fabbri, Alberto

AU - Cox, Maria C

AU - Finolezzi, Erica

AU - Ferrero, Simone

AU - Puccini, Benedetta

AU - Alvarez De Celis, Isabel

AU - Arcari, Annalisa

AU - Marino, Dario

AU - Merli, Michele

AU - Piazza, Francesco

AU - Gentile, Massimo

AU - Pelosini, Matteo

AU - Loseto, Giacomo

AU - Hermine, Olivier

AU - Dreyling, Martin

AU - Ruggeri, Marco

AU - Martelli, Maurizio

AU - Hoster, Eva

AU - Vitolo, Umberto

AU - Network, Fondazione Italiana Linfomi and the Mantle Cell Lymphoma

PY - 2019/6

Y1 - 2019/6

KW - allogeneic transplant

KW - cytarabine

KW - mantle cell lymphoma

KW - prognosis

KW - refractory

U2 - 10.1111/bjh.15643

DO - 10.1111/bjh.15643

M3 - Article

VL - 185

SP - 940

EP - 944

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 5

ER -